Featured Research

from universities, journals, and other organizations

Distinctive developmental origin for a drainage tube in the eye

Date:
July 22, 2014
Source:
PLOS
Summary:
Scientists have conducted a comprehensive exploration of an eye structure known as Schlemm's canal: a key gatekeeper for the proper flow of eye fluid, presenting a number of insights relevant to glaucoma and other diseases.

A Jackson Laboratory based research team has conducted a comprehensive exploration of an eye structure known as Schlemm's canal: a key gatekeeper for the proper flow of eye fluid, presenting a number of insights relevant to glaucoma and other diseases.

Related Articles


For the study publishing July 22 in the Open Access journal PLOS Biology, the researchers at JAX and Tufts University School of Medicine in Boston developed a new, "whole-mount," three-dimensional approach to analyse mouse models that have been engineered to host fluorescent proteins, to determine how Schlemm's canal forms in the eye and in relation to neighbouring tissues.

Due to its roles in fluid flow and intraocular pressure, Schlemm's canal is directly involved in glaucoma, a blinding disease that affects more than 70 million people worldwide.

The report, according to first author Krishnakumar Kizhatil, Ph.D., an associate research scientist in the laboratory of JAX Professor and Howard Hughes Medical Investigator Simon W.M. John, Ph.D., "provides new understanding and tools that will facilitate molecular understanding of Schlemm's canal and its critical -- but poorly understood -- roles in ocular physiology, immunity and health."

The researchers show that Schlemm's canal forms from blood vessels by a novel process of vascular development that they name canalogenesis. Canalogenesis has some similarities to previously established processes of vascular development -- namely angiogenesis, vasculogenesis and lymphangiogenesis -- but also has unique features that make it distinct from each of them. They also identify the first molecule to be functionally implicated in early Schlemm's canal development, namely the KDR receptor, which is also known to play a key role in blood vessel development.

Importantly, the research demonstrates that the endothelial cells lining this drainage tube (called SECs) are novel, having a blend of properties of both of blood and lymphatic endothelial cells. "Thus, Schlemm's canal is a unique vessel with endothelial cells that are highly specialized for its complex functions," Kizhatil says. "This resolves a long-standing controversy about the cellular phenotype of SECs."

Study coauthor Jeffrey K. Marchant, Ph.D., a Tufts research assistant professor and a visiting investigator in the John lab, comments, "This study lays a critical new foundation for determining the functions of Schlemm's canal both in maintaining ocular health and when things go wrong in glaucoma."


Story Source:

The above story is based on materials provided by PLOS. Note: Materials may be edited for content and length.


Journal Reference:

  1. Krishnakumar Kizhatil, Margaret Ryan, Jeffrey K. Marchant, Stephen Henrich, Simon W. M. John. Schlemm's Canal Is a Unique Vessel with a Combination of Blood Vascular and Lymphatic Phenotypes that Forms by a Novel Developmental Process. PLoS Biology, 2014; 12 (7): e1001912 DOI: 10.1371/journal.pbio.1001912

Cite This Page:

PLOS. "Distinctive developmental origin for a drainage tube in the eye." ScienceDaily. ScienceDaily, 22 July 2014. <www.sciencedaily.com/releases/2014/07/140722142509.htm>.
PLOS. (2014, July 22). Distinctive developmental origin for a drainage tube in the eye. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2014/07/140722142509.htm
PLOS. "Distinctive developmental origin for a drainage tube in the eye." ScienceDaily. www.sciencedaily.com/releases/2014/07/140722142509.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins